Navigation Links
Uptake Medical Announces Scott Huennekens Elected to Board of Directors
Date:3/1/2011

IRVINE, Calif., March 1, 2011 /PRNewswire/ -- Uptake Medical® Corp., a developer of medical technologies for the non-surgical treatment of lung diseases including emphysema, announced today that Scott Huennekens, President and CEO of Volcano Corporation, (Nasdaq: VOLC) has joined the company's Board of Directors.

Mr. Huennekens has served as President, CEO and Director of Volcano since April 2002. He led the company from a pre-revenue start-up to its IPO in 2006 and its current market-leading position through consistent growth by utilizing innovative technologies, strong clinical science and focused expansion throughout the global markets. He's been successful in leading both private and public traded companies. From 2000-2002, he headed Digirad Corporation, a medical device imaging company. From 1993-1997 he was at Baxter Healthcare's Cardiovascular Group (Edwards Lifesciences). Mr. Huennekens is a member of the Board of Directors of Medical Device Manufacturers Association (MDMA) and BIOCOM. He received his B.S. in Business Administration from the University of Southern California and an M.B.A. from Harvard Business School.

King Nelson, President and CEO of Uptake Medical said, "We're thrilled to have Scott join our Board of Directors at this important time as we transition from development to commercialization of our InterVapor™ system. He's a very well respected businessman, innovator and strategic thinker, and is experienced in global business operations. He has an incredible understanding of the trends in the medical device marketplace and the clinicians' mindset."

He also added, "Scott is one of the true opinion leaders in the medical device area and we're excited to have him join the company. He'll be very helpful as Uptake Medical moves toward early commercialization outside the U.S. and initiates pivotal U.S. clinical trial activities in 2011. He'll provide critical guidance as Uptake continues to build upon the industry's best clinical results for the large number of emphysema sufferers around the world. Scott has demonstrated success in helping combine innovative technology and science in creative ways to bring treatment solutions to patients."

Mr. Huennekens stated, "I look forward to working with the Uptake Medical team to bring their innovative InterVapor system to patients suffering from emphysema throughout the world. The clinical results to date are very encouraging and offer great promise. I'm excited about Uptake's prospects."

About Uptake Medical

Uptake Medical® Corp. is a developer of medical technologies for the treatment of lung diseases including emphysema. The core InterVapor technology is a simple, minimally invasive, non-implant interventional pulmonary approach designed to measurably improve lung function and patient quality of life. Emphysema afflicts over 4.5 million people in the United States. It is a form of chronic obstructive pulmonary disease (COPD), primarily caused by smoking, and is a major cause of chronic disease and death throughout the world. It accounts for over $40 billion in healthcare costs. More information and a list of participating clinical trial sites can be found at http://www.uptakemedical.com/.


'/>"/>
SOURCE Uptake Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
2. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
3. Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019
4. Uptake Medical Names J.C. MacRae as Chief Financial Officer
5. The Harley Medical Group Sees an Uptake in Surgery Bookings for Christmas
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Globus Medical Raises $110 Million in Series E Financing Round
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. Boston University Biomedical Engineers Find Chink in Bacterias Armor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray ... showcase a healthy CAGR during the forecast period ... in the global digital mobile X-Ray devices market, which is ... in 2017, expanding at a CAGR of 7% over the ... $ opportunity of more than US$ 100 Mn in 2017 ...
(Date:4/19/2017)... , Tenn. and DALLAS , April ... EndoStim, Inc., announced that the first patients in ... the EndoStim device in the Lower Esophageal Sphincter Stimulation ... a minimally-invasive implantable device designed to provide long-term reflux ... neurostimulation. GERD affects nearly 65 million people ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured to have ... UK’s most prestigious award for business success. The company has been recognized ... has grown by a total of 400% over the last six years. , ...
(Date:4/21/2017)... ... 21, 2017 , ... Providing for loved ones before one’s passing is of ... to even begin. “Now more than ever there are some questions that are far ... your family,” said attorney Lisa Edgar Dickman, founder of the Law Offices of Lisa ...
(Date:4/21/2017)... ... ... Westside Dental Associates and its owner, Dr. Les Latner, have ... Latner has become one of the Los Angeles area’s premier dentists. “It’s been an ... their dental needs,” said Dr. Latner, who was recently named Chairperson of the ...
(Date:4/21/2017)... ... April 21, 2017 , ... Each year, everyone is urged to give back ... trees and look forward to a better future. However, supporting the environment should be ... air quality can be two to five times more polluted than outdoor air, reports ...
(Date:4/21/2017)... ... April 21, 2017 , ... Federal mandate, fines, controversy, ... between the Obamacare program that most Republicans love to hate and Texas Agriculture ... kill hogs. , Like Obamacare, the Miller program centers upon a federal ...
Breaking Medicine News(10 mins):